High co‐expression of <scp>SLC7A11</scp> and <scp>GPX4</scp> as a predictor of platinum resistance and poor prognosis in patients with epithelial ovarian cancer-Reference-Cited by-同舟云学术

High co‐expression of SLC7A11 and GPX4 as a predictor of platinum resistance and poor prognosis in patients with epithelial ovarian cancer

Published:2022-11 Issue:S2 Volume:129 Page:40-49
ISSN:1470-0328
Container-title:BJOG: An International Journal of Obstetrics & Gynaecology
language:en
Short-container-title:BJOG

Author:

Wu Xiaodong¹,Shen Shizhen¹,Qin Jiale²,Fei Weidong³,Fan Fengyun¹,Gu Jiaxin¹,Shen Tao¹,Zhang Tao¹,Cheng Xiaodong¹⁴

Affiliation:

1. Department of Gynaecologic Oncology Women's Hospital, Zhejiang University School of Medicine Hangzhou China

2. Department of Ultrasound Women's Hospital, Zhejiang University School of Medicine Hangzhou China

3. Department of Pharmaceutics Women's Hospital, Zhejiang University School of Medicine Hangzhou China

4. Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases Women's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang China

Funder

Natural Science Foundation of Zhejiang Province

Publisher

Wiley

Subject

Obstetrics and Gynecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1471-0528.17327

Reference33 articles.

1. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

2. Ovarian cancer statistics, 2018

3. Epithelial ovarian cancer: Evolution of management in the era of precision medicine

4. Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

5. Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis: mechanism, immunotherapy and role in ovarian cancer;Frontiers in Immunology;2024-08-13

2. Ferroptosis: a novel strategy to overcome chemoresistance in gynecological malignancies;Frontiers in Cell and Developmental Biology;2024-07-09

3. Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance;Life Sciences;2024-07

4. Redox-Regulated Iron Metabolism and Ferroptosis in Ovarian Cancer: Molecular Insights and Therapeutic Opportunities;Antioxidants;2024-06-28

5. Disulfidptosis: A new type of cell death;Apoptosis;2024-06-17